New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | all recent news | >>
October 16, 2014
13:09 EDTAAPLApple says iPhone preorders in China have set a new record
13:09 EDTAAPLApple says iPhone 6/6 Plus launch was biggest ever
Subscribe for More Information
10:01 EDTVIABOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Akamai (AKAM) downgraded to Market Perform from Outperform at Wells Fargo... CGG SA (CGG) downgraded to Reduce from Neutral at Nomura... Central Valley Community (CVCY) downgraded to Hold from Buy at Sandler O'Neill... DSM (RDSMY) downgraded to Neutral from Buy at Nomura... Disney (DIS) downgraded at Guggenheim... Francesca's (FRAN) downgraded to Underperform from Outperform at Macquarie... Netflix (NFLX) downgraded to Fair Value from Buy at CRT Capital... Nordstrom (JWN) downgraded to Neutral from Outperform at Macquarie... Norfolk Southern (NSC) downgraded at Credit Suisse... Rio Tinto (RIO) downgraded to Market Perform at Cowen... Seadrill (SDRL) downgraded to Reduce from Neutral at Nomura... Ternium (TX) downgraded to Neutral from Overweight at JPMorgan... Urban Outfitters (URBN) downgraded to Neutral from Outperform at Macquarie... Viacom (VIAB) downgraded at BofA/Merrill... eBay (EBAY) downgraded to Underperform from Buy at CLSA... lululemon (LULU) downgraded to Underperform from Neutral at Macquarie.
09:46 EDTAAPLApple October weekly volatility elevated into iPad event and Q4
Subscribe for More Information
09:39 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:42 EDTJPMUBS, DOJ in talks for forex rigging settlement, FT reports
Subscribe for More Information
08:21 EDTVIABViacom oversold on affiliate fee and ad fears, says Goldman
Goldman lowered Viacom estimates on a lower ad outlook but believes shares are oversold on affiliate fee and advertising fears. The firm views valuation as compelling against all metrics and expects comps to moderate in Q4 and ratings declines to moderate with new original programing and the current TV season. Shares are Buy rated with a $82 price target. Note BofA/Merrill and Guggenheim downgraded Viacom this morning.
08:06 EDTAAPLAlmunia says political pressure around Google case 'unprecented,' WSJ reports
Subscribe for More Information
07:56 EDTVIABViacom downgraded at BofA/Merrill
Subscribe for More Information
07:48 EDTAAPLSony must decide quickly what to do with smartphone strategy, Nikkei says
Sony's (SNE) "One Sony" strategy is built around providing contents to consumers and smartphones are one of three pillars it sees for growth, but the strategy is "on the brink of collapse" as the company falls behind Apple (AAPL) and Chinese rivals, according to the Nikkei Asian Review. Sony officials are debating whether smartphone operations in Asia should be downsized and whether cutting 1,000 jobs, or 15% of its mobile communications workforce, would be warranted, according to the report. Reference Link
07:45 EDTVIABViacom downgraded at Guggenheim
Subscribe for More Information
07:23 EDTJPMIBF Conferences to hold a summit
Ophthalmology Innovation Summit is being held in Chicago on October 16.
07:17 EDTVIABViacom downgraded to Neutral from Buy at Guggenheim
Subscribe for More Information
06:32 EDTVIABViacom downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
October 15, 2014
17:03 EDTNVSNovartis announces CTL019 data demonstrating efficacy in certain ALL patients
Novartis and the University of Pennsylvania's Perelman School of Medicine announced preliminary results from two pilot clinical trials published in The New England Journal of Medicine, or NEJM, evaluating the efficacy and safety of CTL019 in patients with relapsed/refractory acute lymphoblastic leukemia, or r/r ALL. The studies, conducted by Penn, demonstrated that 27 of 30 pediatric and adult patients, or 90%, experienced complete remissions with the investigational chimeric antigen receptor, or CAR, therapy CTL019. Largest published cohort to date for CTL019, which served as the basis for recent Breakthrough Therapy designation from the FDA. Sustained remissions of up to two years in r/r ALL patients with six-month event-free survival of 67% and overall survival of 78%.
16:00 EDTAAPLOptions Update; October 15, 2014
Subscribe for More Information
13:43 EDTAAPLFirm says more apps downloaded from Google than Apple, 9to5Google says
Subscribe for More Information
13:23 EDTAAPLScreenshots confirm Apple iPad Air 2, iPad mini 3, 9to5Mac reports
Subscribe for More Information
13:09 EDTAAPLEarnings Preview: eBay to report Q3 earnings after PayPal spin-off announcement
eBay (EBAY) is expected to report third quarter earnings after the market close on Wednesday, October 15 with a conference call scheduled for 5:00 pm ET. eBay is a technology company that enables commerce through Marketplaces, Payments, and GSI. EXPECTATIONS: Analysts are looking for earnings per share of 67c on revenue of $4.37B. The consensus range is 65c-72c for EPS, and $4.33B-$4.43B for revenue, according to First Call. LAST QUARTER: eBay reported second quarter EPS of 69c against estimates of 68c on revenue of $4.37B against estimates of $4.38B. The company gave Q3 EPS guidance of 65c-67c and Q3 revenue guidance of $4.3B-$4.4B as well as FY14 EPS guidance of $2.95-$3.00. It narrowed FY14 revenue guidance to $18B-$18.3B from $18B-$18.5B. eBay said Google search algorithm change slowed traffic in June. The company confirmed the Q3 guidance during a conference call in September. NEWS AND STREET RESEARCH: eBay announced in late September that it will separate eBay and PayPal into two independent publicly traded companies, set to be completed in the second half of 2015. eBay Marketplaces President Devin Wenig will be the CEO of the new eBay company and Dan Schulman will become CEO of the new PayPal company. The cost of the transaction has yet to be determined, and the split is not designed to position either business for sale. During its conference call to discuss the split, the company said PayPal is on track to process 1B mobile payments this year and added that Apple (AAPL) could help speed NFC adoption and would be good for PayPal. eBay adds that it has "never been more bullish" on PayPal's prospects. Following the announcement, there were rumors that Google (GOOG) was looking to acquire eBay. Piper Jaffray said the press reports of the talks between the two companies are "largely unsubstantiated." The company was downgraded at JPMorgan, JMP Securities, Jeffries, and Wedbush after the announcement of a split due to increased uncertainty. Investors say the benefit of the spin-off plans are not as clear, unsure if a standalone PayPal is in a better position to compete in the quickly changing digital payments space. Wedbush analysts say a spin-off will not boost the payment processor's business and may have negative consequences for both companies. Investors were also split on how Apple's mobile payments platform will affect eBay and PayPal. RW Baird said Apple iWallet will pose a threat to PayPal, particularly to its opportunities at point-of-sale and Piper Jaffray said the new payments system will further weigh on eBay's multiple over the next six months. JPMorgan, however, said iWallet will be a net positive for payment networks and Citigroup believes the risks from Apple are likely overstated. PRICE ACTION: eBay shares have dropped more 2.21% since the first day of trading following the company's Q2 report. In Wednesday midday trading ahead of its earnings report, eBay shares are trading down 2%.
12:30 EDTAAPLApple to stop selling Fitbit devices in stores, Re/code reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use